Safety and Effectiveness of Longer‐Term Phentermine Use: Clinical Outcomes from an Electronic Health Record Cohort
Obesity2019Vol. 27(4), pp. 591–602
Citations Over TimeTop 10% of 2019 papers
Kristina H. Lewis, Heidi Fischer, Jamy D. Ard, Lee J. Barton, Daniel H. Bessesen, Matthew F. Daley, Jay Desai, Stephanie L. Fitzpatrick, Michael A. Horberg, Corinna Koebnick, Caryn Oshiro, Ayae Yamamoto, Deborah Rohm Young, David Arterburn
Abstract
Greater weight loss without increased risk of incident CVD or death was observed in patients using phentermine monotherapy for longer than 3 months. Despite the limitations of the observational design, this study supports the effectiveness and safety of longer-term phentermine use for low-risk individuals.
Related Papers
- → Greater hunger and less restraint predict weight loss success with phentermine treatment(2015)29 cited
- → The effectiveness and safety of pharmaceuticals to manage excess weight post-bariatric surgery: a systematic literature review(2019)11 cited
- → Early Experience In Multi-Modality Treatment for Obesity(2015)
- → Early Experience with Low-Dose Phentermine for Preoperative Bariatric Weight Loss: A Prospective Randomized Trial(2017)
- → [The relationship between hazard ratio and median survival time].(2019)